NCT06397469 · RECRUITING

Enhancing Attention and Wellbeing Using Digital Therapeutics

This study tests two digital brain-training apps, MediTrain and Worder, in older adults to find the right dose needed to improve attention and cognition. It also looks at whether things like cardiovascular risk or genetic risk scores change how well the training works. This is an early-stage study, not a proven treatment.

You may qualify if

  • 60+ years old (adult)
  • English language fluency
  • owning a smartphone or tablet

You're excluded if

  • Under 60 years old (minor)

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-08-24

View full record on ClinicalTrials.gov

All APOE4 clinical trials